The newly signed law, known as Act 264, bans pharmacy benefit managers from owning pharmacies in the state. It's scheduled to go into effect beginning in 2026.

On a podcast with wellness guru Gary Brecka, HHS Secretary Robert F. Kennedy Jr. said major medical journals have succumbed to the corrupting influence of pharmaceutical companies, and he may ban scientists with the National Institutes of Health (NIH) from publishing in them.

A new report from the American Medical Association reveals that doctors are increasingly likely to work for larger provider groups and hospitals, as single specialty practices slowly disappear. 

The billionaire CEO of Tesla said his time serving in an official capacity in the Trump administration is at an end, though he will remain an advisor.

Walmart is highlighting food and products eligible for purchase using Medicare Advantage supplemental funds through its app, while also using AI to algorithmically help enrollees build diet-appropriate shopping lists.

The analysis—required under an executive order from President Donald Trump—lists overmedicalization, excessive screen time, processed foods and environmental toxins as contributing factors for everything from cancer to ADHD.

Pennant and BrightSpring Health Services have agreed to purchase some healthcare businesses from UnitedHealth and Amedisys. However, it remains unclear whether this will be enough for the DOJ to drop its lawsuit blocking the merger.

Deerfield Management released details on its latest Healthcare Innovations Fund program, promising to finance “promising therapeutics” and “elevating emerging technologies," including artificial intelligence. 

Clairity Breast analyzes screening mammograms and can detect “subtle imaging features” correlated with long-term risk, the Boston-based company notes. 

The device was built as a bridge to transplant for patients with end-stage heart failure. It is made of titanium and approximately the size of an adult’s fist.